enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. 'I have zero desire': Low libido is common in menopause - AOL

   www.aol.com/zero-desire-low-libido-common...

   Low libido is incredibly common in perimenopause and menopause. Treatments include vaginal estrogen, hormone replacement therapy, testosterone, CBT.

3. Flibanserin - Wikipedia

   en.wikipedia.org/wiki/Flibanserin

   Flibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). [4] [5] The medication improves sexual desire, increases the number of satisfying sexual events, and decreases the distress associated with low sexual desire. [6]

4. Is Testosterone The Missing Piece Of The Menopause Puzzle? - AOL

   www.aol.com/testosterone-missing-piece-menopause...

   Nigel Denby, a registered dietitian specialising in the menopause, notes that women of menopausal age - often caring for both children and parents while juggling senior roles at work - are ...

5. Bremelanotide - Wikipedia

   en.wikipedia.org/wiki/Bremelanotide

   Bremelanotide, sold under the brand name Vyleesi, is a medication used to treat low sexual desire in women. [2] Specifically it is used for low sexual desire which occurs before menopause and is not due to medical problems, psychiatric problems, or problems within the relationship.

6. Masturbating Might Relieve Certain Menopause Symptoms ... - AOL

   www.aol.com/masturbating-might-relieve-certain...

   In phase 2, the researchers discovered that 36.2 percent of women going through menopause said that they had an improvement in their symptoms when they masturbated. But while one in 10 women said ...

7. Hypoactive sexual desire disorder - Wikipedia

   en.wikipedia.org/wiki/Hypoactive_sexual_desire...

   Flibanserin was the first medication approved by FDA for the treatment of HSDD in pre-menopausal women. Its approval was controversial and a systematic review found its benefits to be marginal. [15] The only other medication approved in the US for HSDD in pre-menopausal women is bremelanotide, in 2019. [2]